Overall, 36% (84/235) of the samples exhibited PD-L1 expression in tumor cells, including high PD-L1 expression (PD-L1 TPS ≥ 50%) in 12.4% of samples and moderate expression (1% ≤ PD-L1 TPS < 49%) in 23.3% of samples (Table 1). The gene discussed is CD274; the disease is neoplasm.